28 April 2021 | News
Acquired Otsuka Health Solutions (OHS) to transform behavioral healthcare innovations
Photo Credit: Freepik
Holmusk, leading global data science and digital health company building the world's largest Real-World Evidence (RWE) platform for behavioral health, announced that it has acquired Otsuka Health Solutions (OHS), UK-based mental health, predictive analytics provider.
The acquisition from Otsuka Pharmaceutical Europe Ltd (Otsuka) deepens Holmusk's footprint in the UK. With the acquisition, Holmusk adds OHS's award-winning product, Management and Supervision Tool (MaST), to its suite of digital and analytic solutions to improve behavioral health outcomes.
MaST, a powerful and easy-to-use digital platform for care teams, leverages predictive analytics to identify people at greater risk of using crisis services and those who may require different services to support their recovery. As a result, fewer people in crisis require inpatient admissions when compared with standard community management.
With MaST already deployed across several NHS mental health trusts Holmusk will be able to advance into the UK market with momentum. Building on MaST's success, Holmusk now has the opportunity to integrate its cutting-edge technologies to drive the next stage of the product's journey. This strategic acquisition will enable Holmusk to leverage its scientific capabilities and dedicated suite of solutions to support MaST's growth and advance the shift towards data-driven healthcare in the UK and beyond.